JAMA Clinical Reviews: Management of Immunotherapy-Related Toxicities

JAMA Clinical Reviews

2024
October
September
August
July
June
May
April
March
February
January

2023
December
November
October
September
August
July
June
May
April
March
February
January

2022
December
November
October
September
August
July
June
May
April
March
February
January

2021
December
November
October
September
August
July
June
May
April
March
February
January

2020
December
November
October
September
August
July
June
May
April
March
February
January

2019
December
November
October
September
August
July
June
May
April
March
February
January

2018
December
November
October
September
August
July
June
May
March
February
January

2017
December
November
October
September
August
July
June
May
April
March
February
January

2016
December
November
October
September
August
July
June
May
April
March
February
January

2015
December
November
October
September
August
July
June
May

Categories

Now displaying: Page 1

In-depth interviews about current ideas and innovation in medicine, science, and clinical practice.

Management of Immunotherapy-Related Toxicities 0

Feb 2, 2021

Immune checkpoint inhibitors have been a major breakthrough in cancer treatment but can have many serious adverse effects. Pankti Reid, MD, MPH, assistant professor of medicine in rheumatology at the University of Chicago, discusses the pathogenesis, diagnosis, and treatment of toxicities from immune checkpoint inhibitors as outlined by the 2019 NCCN guidelines.

Related Article:

Management of Immunotherapy-Related Toxicities in Patients Treated With Immune Checkpoint Inhibitor Therapy

Download this Episode

0 Comments

Adding comments is not available at this time.

©2024 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies.